UCB Cimzia Advances Pregnancy And Lactation Labeling For Biologics

First industry-sponsored pharmacokinetic studies evaluating transfer of a biologic through placenta and breast milk support US FDA approval of new...

      

Related Stories

• Pregnant Women In Clinical Trials: US FDA Lays Out Different Considerations For Premarket, Postmarket
• Rubraca Ovarian Cancer Maintenance Approval Brings PARP Inhibitor Parity On Broad Indication
• The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees

 

Original Article: UCB Cimzia Advances Pregnancy And Lactation Labeling For Biologics

More From BioPortfolio on "UCB Cimzia Advances Pregnancy And Lactation Labeling For Biologics"